Ilumya (tildrakizumab-asmn)

Adult Dosing .

Dosage forms:  INJ (pre-filled syringe): 100 mg per mL

Special Note

[formulation clarification]

Info: nonproprietary name = tildrakizumab-asmn

psoriasis, mod-severe plaque

[100 mg SC q12wk]

Start: 100 mg SC x1 on wk 0, 4

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.